These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma. Murray GI; Paterson PJ; Weaver RJ; Ewen SW; Melvin WT; Burke MD Cancer; 1993 Jan; 71(1):36-43. PubMed ID: 8380119 [TBL] [Abstract][Full Text] [Related]
4. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Nakajima T; Wang RS; Nimura Y; Pin YM; He M; Vainio H; Murayama N; Aoyama T; Iida F Carcinogenesis; 1996 Jul; 17(7):1477-81. PubMed ID: 8706252 [TBL] [Abstract][Full Text] [Related]
6. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase. Fritz P; Behrle E; Beaune P; Eichelbaum M; Kroemer HK Histochemistry; 1993 Jun; 99(6):443-51. PubMed ID: 8407368 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cytochrome P450 expression in human oesophageal mucosa. Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460 [TBL] [Abstract][Full Text] [Related]
9. Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder. Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD Int J Exp Pathol; 1995 Aug; 76(4):271-6. PubMed ID: 7547441 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. de Waziers I; Cugnenc PH; Yang CS; Leroux JP; Beaune PH J Pharmacol Exp Ther; 1990 Apr; 253(1):387-94. PubMed ID: 2329521 [TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD J Pathol; 1995 Oct; 177(2):147-52. PubMed ID: 7490681 [TBL] [Abstract][Full Text] [Related]
12. Drug metabolizing enzyme systems in the houbara bustard (Chlamydotis undulata). Bailey TA; John A; Mensah-Brown EP; Garner A; Samour J; Raza H Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Oct; 120(3):365-72. PubMed ID: 9827052 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Yokose T; Doy M; Taniguchi T; Shimada T; Kakiki M; Horie T; Matsuzaki Y; Mukai K Virchows Arch; 1999 May; 434(5):401-11. PubMed ID: 10389623 [TBL] [Abstract][Full Text] [Related]
14. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Godoy W; Albano RM; Moraes EG; Pinho PR; Nunes RA; Saito EH; Higa C; Filho IM; Kruel CD; Schirmer CC; Gurski R; Lang MA; Pinto LF Carcinogenesis; 2002 Apr; 23(4):611-6. PubMed ID: 11960914 [TBL] [Abstract][Full Text] [Related]
15. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607 [TBL] [Abstract][Full Text] [Related]
16. Activation of microsomal epoxide hydrolase by interaction with cytochromes P450: kinetic analysis of the association and substrate-specific activation of epoxide hydrolase function. Taura Ki K; Yamada H; Naito E; Ariyoshi N; Mori Ma MA; Oguri K Arch Biochem Biophys; 2002 Jun; 402(2):275-80. PubMed ID: 12051674 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome p450 and glutathione transferase expression in human breast cancer. El-Rayes BF; Ali S; Heilbrun LK; Lababidi S; Bouwman D; Visscher D; Philip PA Clin Cancer Res; 2003 May; 9(5):1705-9. PubMed ID: 12738724 [TBL] [Abstract][Full Text] [Related]
18. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. Schuetz JD; Kauma S; Guzelian PS J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787 [TBL] [Abstract][Full Text] [Related]
19. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Snyder R; Chepiga T; Yang CS; Thomas H; Platt K; Oesch F Toxicol Appl Pharmacol; 1993 Oct; 122(2):172-81. PubMed ID: 8211999 [TBL] [Abstract][Full Text] [Related]
20. Species differences in the distribution of drug-metabolizing enzymes in the pancreas. Ulrich AB; Standop J; Schmied BM; Schneider MB; Lawson TA; Pour PM Toxicol Pathol; 2002; 30(2):247-53. PubMed ID: 11950168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]